Menu Search
Equities

ImpediMed Ltd

IPD:ASX

ImpediMed Ltd

Actions
Health CareMedical Equipment and Services
  • Price (AUD)0.054
  • Today's Change0.001 / 1.89%
  • Shares traded2.29m
  • 1 Year change-60.00%
  • Beta2.7151
Data delayed at least 20 minutes, as of Nov 18 2024 04:56 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in AUDIncome statement in AUDView more

Year on year ImpediMed Ltd had revenues fall -9.04% from 11.34m to 10.32m, though the company grew net income from a loss of 20.52m to a smaller loss of 19.79m.
Gross margin87.27%
Net profit margin-191.78%
Operating margin-191.46%
Return on assets-34.20%
Return on equity-38.95%
Return on investment-37.62%
More ▼

Cash flow in AUDView more

In 2024, cash reserves at ImpediMed Ltd fell by 21.08m. Cash Flow from Financing was negative, which signals that this company did not need to attract significant financing from outside sources. In addition the company used 17.79m for operations while cash used for investing totalled 3.11m.
Cash flow per share-0.0087
Price/Cash flow per share--
Book value per share0.0201
Tangible book value per share0.0122
More ▼

Balance sheet in AUDView more

ImpediMed Ltd has little financial risk as the capital structure does not rely on leverage.
Current ratio6.33
Quick ratio6.16
Total debt/total equity0.028
Total debt/total capital0.0273
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.